Clinical Trial New Zealand Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2011
NCT01420666
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Clinical Trial New Zealand Ltd, 32 Kahikatea Drive, Hamilton, New Zealand

Active Ingredients

Drugs in Phase 3 Trials (2)

acetaminophen (tylenol) (2 trials)

ibuprofen (motrin) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoarthritis (Phase 3)

Toothache (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2